US Equity
CGEN
— COMPUGEN LTD.Compugen Ltd. is a clinical-stage cancer immunotherapy company developing novel therapeutic protein candidates and antibodies for cancer treatment.
💰 Market cap: $225.04M📍 Azrieli Center, 26 Harokmim St., Bldg D, NaN, HOLON, 5885849 IL🏷️ Biotechnology & Medical Research💵 Previous close: $2.28🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.28 |
| 2026-07-23 | $2.34 |
| 2026-07-22 | $2.42 |
| 2026-07-21 | $2.49 |
| 2026-07-20 | $2.34 |
| 2026-07-17 | $2.37 |
| 2026-07-16 | $2.33 |
| 2026-07-15 | $2.36 |
| 2026-07-14 | $2.30 |
| 2026-07-13 | $2.30 |
| 2026-07-10 | $2.39 |
| 2026-07-09 | $2.47 |
| 2026-07-08 | $2.41 |
| 2026-07-07 | $2.39 |
| 2026-07-06 | $2.36 |
| 2026-07-02 | $2.28 |
| 2026-07-01 | $2.13 |
| 2026-06-30 | $2.14 |
| 2026-06-29 | $2.16 |
| 2026-06-26 | $2.09 |
| 2026-06-25 | $2.02 |
| 2026-06-24 | $2.01 |
| 2026-06-23 | $2.02 |
| 2026-06-22 | $2.07 |
| 2026-06-18 | $2.01 |
| 2026-06-17 | $1.99 |
| 2026-06-16 | $2.03 |
| 2026-06-15 | $2.02 |
| 2026-06-12 | $2.04 |
| 2026-06-11 | $2.04 |
| 2026-06-10 | $1.96 |
| 2026-06-09 | $2.02 |
| 2026-06-08 | $2.04 |
| 2026-06-05 | $2.10 |
| 2026-06-04 | $2.22 |
| 2026-06-03 | $2.19 |
| 2026-06-02 | $2.26 |
| 2026-06-01 | $2.46 |
| 2026-05-29 | $2.63 |
| 2026-05-28 | $2.78 |
| 2026-05-27 | $2.76 |
| 2026-05-26 | $2.65 |
| 2026-05-22 | $2.80 |
| 2026-05-21 | $2.61 |
| 2026-05-20 | $2.71 |
| 2026-05-19 | $2.73 |
| 2026-05-18 | $2.86 |
| 2026-05-15 | $2.75 |
| 2026-05-14 | $3.03 |
| 2026-05-13 | $2.85 |
| 2026-05-12 | $2.83 |
| 2026-05-11 | $2.87 |
| 2026-05-08 | $2.90 |
| 2026-05-07 | $2.86 |
| 2026-05-06 | $2.76 |
| 2026-05-05 | $2.72 |
| 2026-05-04 | $2.64 |
| 2026-05-01 | $2.71 |
| 2026-04-30 | $2.66 |
| 2026-04-29 | $2.60 |
| 2026-04-28 | $2.73 |